Litifilimab

Modify Date: 2025-08-24 13:00:58

Litifilimab Structure
Litifilimab structure
Common Name Litifilimab
CAS Number 2407378-48-5 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Litifilimab


Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study[1][2].

 Names

Name Litifilimab

 Litifilimab Biological Activity

Description Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study[1][2].
Related Catalog
Target

C-type lectin domain family 4 member C, CLEC4C

References

[1]. Cho SK, et al. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus. Expert Opin Investig Drugs. 2023 May;32(5):345-353.  

[2]. Litifilimab. IMGT/mAb-DB.

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.